The present invention provides compounds of Formula (I):
wherein A, X and Y are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.
本发明提供了式 (I) 的化合物:
其中A、X和Y如说明书中所定义,以及包含任何此类新型化合物的组合物。这些化合物是髓
过氧化物酶(MPO)
抑制剂和/或嗜酸性粒细胞
过氧化物酶(EPX)
抑制剂,可用作药物。